GlassScriptPhysician profile
Allen Lloyd Nedley
NPI 1154828234
$15,566.33
in general payments reported to CMS, 2019-2025
8 companies · $6,713 in 2025
The $6,713 reported for 2025 was more than what 85% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $169 · 2023: $2,568 · 2024: $6,117 · 2025: $6,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $2,790 · Food and Beverage: $2,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,246.00 |
| Travel and Lodging | $2,790.45 |
| Food and Beverage | $2,361.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbutus Medical, INC | $10,246.00 | 2023-2025 | |
| Stryker Corporation | $2,066.19 | 2022-2025 | Pro, Gamma, Axsos |
| Smith+Nephew, INC. | $1,965.44 | 2023-2025 | Evos, Trigen Intertan |
| Depuy Synthes Sales INC. | $577.29 | 2023-2025 | Na, Tfn-Advance, Va-Lcp |
| Arthrex, INC. | $471.35 | 2024 | |
| Medacta USA, INC. | $126.73 | 2022 | |
| Pylant Medical | $93.14 | 2024 | |
| Vericel Corporation | $20.19 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allen Nedley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.